1. Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. (11th October 2018) Authors: Cottu, P; D'Hondt, V; Dureau, S; Lerebours, F; Desmoulins, I; Heudel, P -E; Duhoux, F P; Levy, C; Mouret-Reynier, M -A; Dalenc, F; Frenel, J -S; Jouannaud, C; Venat-Bouvet, L; Nguyen, S; Ferrero, J -M; Canon, J -L; Grenier, J; Callens, C; Gentien, D; Lemonnier, J Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. (13th March 2019) Authors: Trédan, O; Wang, Q; Pissaloux, D; Cassier, P; de la Fouchardière, A; Fayette, J; Desseigne, F; Ray-Coquard, I; de la Fouchardière, C; Frappaz, D; Heudel, P -E; Bonneville-Levard, A; Fléchon, A; Sarabi, M; Guibert, P; Bachelot, T; Pérol, M; You, B; Bonnin, N; Collard, O Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗